Assessing the value of risk predictions by using risk stratification tables

Annals of Internal Medicine

Volumn 149, Issue 10, 2008, Pages 751-760

  Janes, Holly ^a,b   Pepe, Margaret S ^a,b   Gu, Wen ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CALIBRATION; CANCER RISK; HUMAN; MEDICAL DECISION MAKING; MEDICAL PRACTICE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIMULATION;

EID: 56549122629     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-149-10-200811180-00009     Document Type: Review

References (27)

1. Cook NR, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med. 2006;145:21-9.
2. Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med. 2008;148:337-47. [PMID: 18316752]
3. Lauer MS, Pothier CE, Magid DJ, Smith SS, Kattan MW. An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram. Ann Intern Med. 2007;147:821-8. [PMID: 18087052]
4. van der Steeg WA, Boekholdt SM, Stein EA, El-Harchaoui K, Stroes ES, Sandhu MS, et al. Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk. Ann Intern Med. 2007;146:640-8. [PMID: 17470832]
5. Parikh NI, Pencina MJ, Wang TJ, Benjamin EJ, Lanier KJ, Levy D, et al. A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med. 2008;148:102-10. [PMID: 18195335]
6. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928-35. [PMID: 17309939]
7. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:2631-9. [PMID: 17182988]
8. Chlebowski RT, Collyar DE, Somerfield MR, Pfister DG. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene. J Clin Oncol. 1999;17:1939-55. [PMID: 10561236]
9. Levine M, Moutquin JM, Walton R, Feightner J. Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on preventive health care and the Canadian Breast Cancer Initiative's steering committee on clinical practice guidelines for the care and treatment of breast cancer. Can Med Assoc J. 2001;164:1681-90.
10. Harrell FE. Regression Modelling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer-Verlag; 2001.
11. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley; 1989: Section 5.2.2.
12. Cook NR. Comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929). Stat Med. 2008; 27:191-5. [PMID: 17671959]
13. Cook NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem. 2008;54:17-23. [PMID: 18024533]
14. Pencina MJ, Vasan RS, D'Agostino RB Sr. Algorithms for assessing cardiovascular risk in women [Letter]. JAMA. 2007;298:175-6; author reply 177-8. [PMID: 17622595]
15. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-72; discussion 207-12. [PMID: 17569110]
16. Pepe MS, Feng Z, Huang Y, Longton G, Prentice R, Thompson IM, et al. Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol. 2008;167:362-8. [PMID: 17982157]
17. Prentice RL, Pyke R. Logistic disease incidence models and case-control studies. Biometrika. 1979;66:403-11.
18. Benichou J, Gail MH. Methods of inference for estimates of absolute risk derived from population-based case-control studies. Biometrics. 1995;51:182-94. [PMID: 7766773]
19. Langholz B, Borgan O. Estimation of absolute risk from nested case-control data. Biometrics. 1997;53:767-74. [PMID: 9192463]
20. Huang Y, Pepe MS. A parametric ROC model based approach for evaluating the predictiveness of continuous markers in case- control studies. Collection of Biostatistics Research Archive. Accessed at www.bepress.com/ uwbiostat/paper318 on 29 September 2008.
21. Huang Y, Pepe MS. Semiparametric methods for evaluating the covariate-specific predictiveness of continuous markers in matched case- control studies. Collection of Biostatistics Research Archive. Accessed at www.bepress.com /uwbiostat/paper329 on 29 September 2008.
22. Pauker SG, Kassirer JP. Therapeutic decision making: a cost-benefit analysis. N Engl J Med. 1975;293:229-34. [PMID: 1143303]
23. Pepe MS. Invited discussion of "The skill plot: a graphical technique for evaluating diagnostic tests". Biometrics. 2008;64:256-8.
24. Huang Y, Sullivan Pepe M, Feng Z. Evaluating the predictiveness of a continuous marker. Biometrics. 2007;63:1181-8. [PMID: 17489968]
25. Copas JB. Regression, prediction, and shrinkage. Journal of the Royal Statistical Society, Series B. 1983;45:311-54.
26. Chatfield C. Model uncertainty, data mining, and statistical inference. Journal of the Royal Statistical Society, Series A. 1995;158:419-66.
27. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-87. [PMID: 8668867]